These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17094053)

  • 1. Aldosterone antagonism in an inflammatory state: evidence for myocardial protection.
    Ramires FJ; Salemi VM; Ianni BM; Fernandes F; Martins DG; Billate A; Neto EC; Mady C
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):162-7. PubMed ID: 17094053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy.
    Pimentel Wde S; Ramires FJ; Lanni BM; Salemi VM; Bilate AM; Cunha-Neto E; Oliveira AM; Fernandes F; Mady C
    Clinics (Sao Paulo); 2012 Sep; 67(9):1063-9. PubMed ID: 23018305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction].
    Hayashi M
    J Cardiol; 2004 Feb; 43(2):88-91. PubMed ID: 15046031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological Correlates of Global and Segmental Left Ventricular Systolic Dysfunction in Experimental Chronic Chagas Cardiomyopathy.
    de Oliveira LF; Romano MM; de Carvalho EE; Cabeza JM; Salgado HC; Fazan Júnior R; Costa RS; da Silva JS; Higuchi Mde L; Maciel BC; Cunha-Neto E; Marin-Neto JA; Simões MV
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26796255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
    Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
    Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
    Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
    Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone blockade reduces mortality without changing cardiac remodeling in spontaneously hypertensive rats.
    Cezar MD; Damatto RL; Martinez PF; Lima AR; Campos DH; Rosa CM; Guizoni DM; Bonomo C; Cicogna AC; Gimenes R; Pagan LU; Okoshi MP; Okoshi K
    Cell Physiol Biochem; 2013; 32(5):1275-87. PubMed ID: 24281393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
    Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
    Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone receptor blockade prevents the transition to cardiac pump dysfunction induced by beta-adrenoreceptor activation.
    Veliotes DG; Woodiwiss AJ; Deftereos DA; Gray D; Osadchii O; Norton GR
    Hypertension; 2005 May; 45(5):914-20. PubMed ID: 15837836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of enalapril and spironolactone in hamsters with dilated cardiomyopathy.
    Goineau S; Pape D; Guillo P; Ramée MP; Bellissant E
    J Cardiovasc Pharmacol; 2003 Jan; 41(1):49-59. PubMed ID: 12500021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
    Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone inhibition and cardiovascular protection: more important than it once appeared.
    Martinez FA
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):345-50. PubMed ID: 20676926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease.
    Edwards NC; Ferro CJ; Kirkwood H; Chue CD; Young AA; Stewart PM; Steeds RP; Townend JN
    Am J Cardiol; 2010 Nov; 106(10):1505-11. PubMed ID: 21059444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of storage of interstitial myocardial collagen on the overlife rate of patients with idiopathic and Chagasic dilated cardiomyopathy.
    Nunes VL; Ramires FJ; Pimentel Wde S; Fernandes F; Ianni BM; Mady C
    Arq Bras Cardiol; 2006 Dec; 87(6):757-62. PubMed ID: 17262114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis.
    Bilate AM; Salemi VM; Ramires FJ; de Brito T; Silva AM; Umezawa ES; Mady C; Kalil J; Cunha-Neto E
    Microbes Infect; 2003 Oct; 5(12):1116-24. PubMed ID: 14554253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Air Pollution's Impact on Cardiac Remodeling in an Experimental Model of Chagas Cardiomyopathy.
    Fonseca KCB; Pessoa FG; Ribeiro ODN; Hotta VT; Ianni BM; Fernandes F; Ferreira Rivero DHR; Saldiva PHN; Mady C; Ramires FJA
    Front Cell Infect Microbiol; 2022; 12():830761. PubMed ID: 35928208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients.
    Orea-Tejeda A; Colín-Ramírez E; Castillo-Martínez L; Asensio-Lafuente E; Corzo-León D; González-Toledo R; Rebollar-González V; Narváez-David R; Dorantes-García J
    Rev Invest Clin; 2007; 59(2):103-7. PubMed ID: 17633796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of torasemide and spironolactone on adverse cardiac remodeling in a rat model of dilated cardiomyopathy.
    Arumugam S; Sreedhar R; Karuppagounder V; Harima M; Nakamura M; Suzuki H; Sone H; Watanabe K
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28664677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.